$134.22
-2.02-1.48%
At Close: -
$134.22
00.00%
After Hours: 4:01 PM EDT
15 minutes delayed
Houlihan Lokey
HLINYSE
Houlihan Lokey (NYSE:HLI) Stock, Analyst Ratings, Price Targets, Forecasts
Houlihan Lokey Inc has a consensus price target of $93.13 based on the ratings of 29 analysis. The 3 most-recent analyst ratings were released by UBS, UBS, and UBS on May 14, 2024, February 5, 2024, and February 2, 2024, respectively. With an average price target of $144 between UBS, UBS, and UBS, there's an implied 7.29% upside for Houlihan Lokey Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
JMP Securities
Keefe, Bruyette & Woods
Morgan Stanley
Keefe, Bruyette & Woods
1calculated from analyst ratings
Analyst Ratings for Houlihan Lokey
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | Buy Now | 8.03% | UBS | Brennan Hawken | $157 → $145 | Maintains | Buy | Get Alert |
| 04/09/2024 | Buy Now | — | JMP Securities | Devin Ryan | — | Reiterates | → Market Perform | Get Alert |
| 02/05/2024 | Buy Now | 8.03% | UBS | Brennan Hawken | $142 → $145 | Maintains | Buy | Get Alert |
| 02/02/2024 | Buy Now | 5.8% | UBS | Brennan Hawken | $136 → $142 | Maintains | Buy | Get Alert |
| 01/29/2024 | Buy Now | -5.38% | Keefe, Bruyette & Woods | Michael Brown | → $127 | Reinstates | → Market Perform | Get Alert |
| 01/09/2024 | Buy Now | 1.33% | UBS | Brennan Hawken | $124 → $136 | Maintains | Buy | Get Alert |
| 10/03/2023 | Buy Now | -7.61% | UBS | Brennan Hawken | $118 → $124 | Maintains | Buy | Get Alert |
| 07/12/2023 | Buy Now | -24.75% | Morgan Stanley | Manan Gosalia | $81 → $101 | Maintains | Equal-Weight | Get Alert |
| 05/10/2023 | Buy Now | -30.71% | Keefe, Bruyette & Woods | Matthew Moon | $94 → $93 | Maintains | Market Perform | Get Alert |
| 05/10/2023 | Buy Now | -39.65% | Morgan Stanley | Manan Gosalia | $78 → $81 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | Buy Now | -29.22% | Keefe, Bruyette & Woods | Matthew Moon | $90 → $95 | Maintains | Market Perform | Get Alert |
| 10/31/2022 | Buy Now | -41.89% | Morgan Stanley | Manan Gosalia | $75 → $78 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | Buy Now | -24.01% | UBS | Brennan Hawken | $105 → $102 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | -38.91% | Morgan Stanley | Manan Gosalia | $95 → $82 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 07/08/2022 | Buy Now | -41.89% | Piper Sandler | Jeffery Harte | $80 → $78 | Maintains | Underweight | Get Alert |
| 05/23/2022 | Buy Now | -29.22% | Goldman Sachs | Richard Ramsden | $106 → $95 | Maintains | Buy | Get Alert |
| 04/12/2022 | Buy Now | -17.3% | Goldman Sachs | Richard Ramsden | $127 → $111 | Maintains | Buy | Get Alert |
| 04/07/2022 | Buy Now | -43.38% | Piper Sandler | Jeffery Harte | $92 → $76 | Downgrade | Neutral → Underweight | Get Alert |
| 03/25/2022 | Buy Now | -29.22% | Morgan Stanley | Manan Gosalia | $97 → $95 | Maintains | Underweight | Get Alert |
| 03/22/2022 | Buy Now | -31.46% | Piper Sandler | Jeffery Harte | $106 → $92 | Maintains | Neutral | Get Alert |
| 03/09/2022 | Buy Now | -21.03% | Piper Sandler | Jeffery Harte | $122 → $106 | Maintains | Neutral | Get Alert |
| 03/08/2022 | Buy Now | -27.73% | Morgan Stanley | Manan Gosalia | $106 → $97 | Maintains | Underweight | Get Alert |
| 02/09/2022 | Buy Now | -21.03% | Morgan Stanley | Manan Gosalia | $101 → $106 | Maintains | Underweight | Get Alert |
| 01/11/2022 | Buy Now | -24.75% | Morgan Stanley | Manan Gosalia | $97 → $101 | Maintains | Underweight | Get Alert |
| 01/06/2022 | Buy Now | -6.12% | Goldman Sachs | Richard Ramsden | $116 → $126 | Upgrade | Neutral → Buy | Get Alert |
| 01/04/2022 | Buy Now | -13.57% | UBS | Brennan Hawken | → $116 | Upgrade | Neutral → Buy | Get Alert |
| 12/08/2021 | Buy Now | -27.73% | Morgan Stanley | Manan Gosalia | — | Maintains | Underweight | Get Alert |
| 10/29/2021 | Buy Now | -21.03% | Morgan Stanley | — | — | Maintains | Underweight | Get Alert |
| 07/14/2021 | Buy Now | -40.4% | Keefe, Bruyette & Woods | Michael Brown | — | Downgrade | Market Perform → Underperform | Get Alert |
FAQ
What is the target price for Houlihan Lokey (HLI) stock?
The latest price target for Houlihan Lokey (NYSE:HLI) was reported by UBS on May 14, 2024. The analyst firm set a price target for $145.00 expecting HLI to rise to within 12 months (a possible 8.03% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Houlihan Lokey (HLI)?
The latest analyst rating for Houlihan Lokey (NYSE:HLI) was provided by UBS, and Houlihan Lokey maintained their buy rating.
When was the last upgrade for Houlihan Lokey (HLI)?
The last upgrade for Houlihan Lokey Inc happened on July 18, 2022 when Morgan Stanley raised their price target to $82. Morgan Stanley previously had an underweight for Houlihan Lokey Inc.
When was the last downgrade for Houlihan Lokey (HLI)?
The last downgrade for Houlihan Lokey Inc happened on April 7, 2022 when Piper Sandler changed their price target from $92 to $76 for Houlihan Lokey Inc.
When is the next analyst rating going to be posted or updated for Houlihan Lokey (HLI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Houlihan Lokey, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Houlihan Lokey was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
Is the Analyst Rating Houlihan Lokey (HLI) correct?
While ratings are subjective and will change, the latest Houlihan Lokey (HLI) rating was a maintained with a price target of $157.00 to $145.00. The current price Houlihan Lokey (HLI) is trading at is $134.22, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.